Armata Pharmaceuticals (ARMP)Madison Asset Management, LLC opened a new position $21.6M

2.11M

Shares reported

0.27%

Disclosed portfolio weight

$21.6M

Reported value

Holdings as of

Mar 31, 2026

Filed

May 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 25, 2026Company filing · Form 8-K · ResultsReported its results
2. Apr 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 27, 2026, Armata Pharmaceuticals, Inc. (the “Company”) announced that the Board of Directors (the “Board”) appointed Dr. Daniel Gilmer, 39, as a member of the Board, effective as of April 24, 2026, to serve until the Company’s next annual meeting of the Company’s shareholders.”
3. Apr 24, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 24, 2026, the Board appointed Dr. Gilmer to serve on the Nominating and Corporate Governance Committee of the Board (the “Nominating and Corporate Governance Committee”), effective as of June 24, 2026.”

What came next

1. May 12, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 2 more items)
2. Jul 17, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 17, 2026, the Board of Directors (the “ Board ”) of Armata Pharmaceuticals, Inc. (the “ Company ”) promoted and appointed David House as the Company’s Chief Financial Officer, effective July 17, 2026.”
3. Aug 12, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Armata Pharmaceuticals

OQRO holds no insider, Congress, fund or contract record for Armata Pharmaceuticals dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ARMP page.

How this filing works

• SEC Form 13F